{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fprogressive-ros1-altered-advanced-nsclc-d9pZi_Gv","width":444,"version":"1.0","type":"rich","title":"Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/11472c10-c513-4a1f-b3e9-b34f7199061b/7151-podcast-2-ros1-wc-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9effa2b6-381f-4a2d-8f11-c6b1e9e44e85\" height=\"200\" width=\"100%\" title=\"Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Audio podcast with highlights from a live webinar covering available clinical data and approved treatments options for progressive ROS1-altered advanced non-small-cell lung cancer (NSCLC), including emerging options on the horizon. Listen to the experts review and discuss their perspectives and summarize the clinical data in support of guideline second-line and beyond treatments. "}